The Pharma Partnering Summit 2026 announces its highly anticipated return as the premier global forum dedicated exclusively to Business Development & Licensing (BD&L) in the pharmaceutical and biotechnology sectors. With flagship events planned in Basel, Switzerland (20–21 May 2026) and San Diego, California (29–30 April 2026), the summit will deliver an unrivaled platform for deal-makers, senior executives, investors, and innovators seeking strategic partnerships, licensing opportunities, and capital engagement worldwide.

Across both EU and US editions, Pharma Partnering Summit is focused on practical BD&L outcomes, connecting companies actively pursuing collaborations in licensing, research partnerships, joint ventures, mergers and acquisitions, external innovation, investment, and fundraising. The summit is carefully curated to ensure that attendees engage in high-value conversations with peers who share aligned strategic objectives.

A Strategic Summit for Global BD&L Professionals

In today’s highly competitive and rapidly evolving life sciences landscape, pharma and biotech organizations must accelerate innovation by forging the right collaborations at the right time. Pharma Partnering Summit is designed to address these challenges by offering a highly structured environment that maximizes deal flow, strategic alignment, and measurable outcomes.

Key features of the summit include:

• Targeted Partnering: Pre-arranged one-to-one partnering meetings with senior decision-makers to explore licensing deals, co-development opportunities, and investment partnerships.
• Showcase Presentations: Focused company presentations enabling organizations to pitch assets, platforms, and technologies to a qualified audience of BD&L professionals.
• Expert Panels: Thought leadership sessions featuring industry experts sharing insights on deal structuring, emerging therapeutic trends, market access considerations, and global partnering strategies.
• Networking Sessions: Dedicated networking time throughout the event to facilitate relationship-building with potential collaborators, investors, and strategic partners.

A Curated, Invitation-Focused Experience

Unlike large-scale trade shows, Pharma Partnering Summit maintains a curated, senior-level format, ensuring that participants engage with relevant stakeholders in a productive and confidential setting. Attendance is limited to ensure quality interactions, with a strong emphasis on decision-makers actively involved in partnering and transaction execution.

Who Should Attend:

• Pharma Partnering Summit is designed for:
• Senior BD&L professionals from pharmaceutical and biotechnology companies
• Alliance management and external innovation leaders
• Investors, venture capital firms, and corporate development teams
• Companies seeking licensing partners or strategic investment
• Technology licensors and asset owners pursuing commercialization pathways
• Legal, IP, and commercialization strategists supporting deal execution

Registration and Opportunities

Registration, sponsorship, and presentation opportunities for both Pharma Partnering Summit EU & US 2026 are now open. Organizations can participate as delegates, sponsors, exhibitors, or presenters, with tailored options designed to support visibility, deal-making, and strategic engagement.

Join pharma and biotech leaders shaping the next wave of global BD&L outcomes.
Visit https://pharma-partnering-summit.com/registration.html
 to secure your place.